475830.KQ
Orum Therapeutics, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 54,500.00
−3.20%Margins
Gross margin
-6803.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
25.9%
Return on equity
16.5%
Return on assets
-11.9%
Return on invested capital
0.00x
Asset turnover
-KRW 52.2B
Cash from operations
KRW 11.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026